Disc Medicine | 10-Q: Quarterly report
Express News | Disc Medicine Inc: Cash and Cash Equivalents Were $342.6 Mln as of March 31, 2024, Which Are Expected to Fund Our Operational Plans Well Into 2026
Express News | Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
Express News | Disc Medicine Q1 Operating Income USD -31.462 Million Vs. Ibes Estimate USD -27 Million
Express News | Disc Medicine Q1 Basic EPS USD -1.09 Vs. Ibes Estimate USD -1
Express News | Disc Medicine Q1 Operating Expenses USD 31.462 Million
Disc Medicine 1Q Loss/Shr $1.09 >IRON
Disc Medicine 1Q Loss/Shr $1.09 >IRON
Disc Medicine(IRON.US) Director Sells US$5,754.97 in Common Stock
$Disc Medicine(IRON.US)$ Director White William Richard sold 201 shares of common stock on May 1, 2024 at an average price of $28.6317 for a total value of $5,754.97.Source: Announcement What is state
Disc Medicine(IRON.US) Director Sells US$81,406.83 in Common Stock
$Disc Medicine(IRON.US)$ Director White William Richard sold 2,560 shares of common stock on Apr 11, 2024 at an average price of $31.7995 for a total value of $81,406.83.Source: Announcement What is s
HROW, HCAT and EGRX Are Among After Hour Movers
Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE), Disc Medicine (IRON) and Avita Medical (RCEL)
Express News | Stifel Maintains Buy on Disc Medicine, Raises Price Target to $73
Analysts Conflicted on These Healthcare Names: Legend Biotech (LEGN), Intuitive Surgical (ISRG) and Disc Medicine (IRON)
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Analysts Offer Insights on Healthcare Companies: Assembly Biosciences (ASMB), Natera (NTRA) and Disc Medicine (IRON)
Disc Medicine's Bitopertin Shows Promise in EPP Study
Disc Medicine (IRON) Down on Mixed Results From AURORA Study
Disc Medicine Price Target Cut to $40.00/Share From $75.00 by Morgan Stanley
Disc Medicine Price Target Cut to $40.00/Share From $75.00 by Morgan Stanley
BMO Capital Cuts Disc Medicine's Price Target to $50 From $80, Maintains Outperform Rating
Disc Medicine (IRON) has an average rating of outperform and price targets ranging from $40 to $85, according to analysts polled by Capital IQ. Price: 31.02, Change: -3.19, Percent Change: -9.34
Disc Medicine Is Maintained at Buy by Stifel
Disc Medicine Is Maintained at Buy by Stifel
No Data